Mutations in gamma adducin are associated with inherited cerebral palsy. by Kruer, MC et al.
ORIGINAL ARTICLE
Mutations in Gamma Adducin Are
Associated With Inherited Cerebral Palsy
Michael C. Kruer, MD,1 Tyler Jepperson, BS,1 Sudeshna Dutta, PhD,2
Robert D. Steiner, MD,2,3 Ellen Cottenie, BS,4 Lynn Sanford, BS,2
Mark Merkens, MD,3,5 Barry S. Russman, MD,5,6 Peter A. Blasco, MD,3,5,6
Guang Fan, MD, PhD,7 Jeffrey Pollock, MD,8 Sarah Green, BS,9
Randall L. Woltjer, MD, PhD,9 Catherine Mooney, PhD,10
Doris Kretzschmar, PhD,2 Coro Paisan-Ruiz, PhD,11,12 and
Henry Houlden, MBBS, PhD4
Objective: Cerebral palsy is estimated to affect nearly 1 in 500 children, and although prenatal and perinatal contrib-
utors have been well characterized, at least 20% of cases are believed to be inherited. Previous studies have identi-
fied mutations in the actin-capping protein KANK1 and the adaptor protein-4 complex in forms of inherited cerebral
palsy, suggesting a role for components of the dynamic cytoskeleton in the genesis of the disease.
Methods: We studied a multiplex consanguineous Jordanian family by homozygosity mapping and exome sequenc-
ing, then used patient-derived fibroblasts to examine functional consequences of the mutation we identified in vitro.
We subsequently studied the effects of adducin loss of function in Drosophila.
Results: We identified a homozygous c.1100G>A (p.G367D) mutation in ADD3, encoding gamma adducin in all
affected members of the index family. Follow-up experiments in patient fibroblasts found that the p.G367D muta-
tion, which occurs within the putative oligomerization critical region, impairs the ability of gamma adducin to associ-
ate with the alpha subunit. This mutation impairs the normal actin-capping function of adducin, leading to both
abnormal proliferation and migration in cultured patient fibroblasts. Loss of function studies of the Drosophila addu-
cin ortholog hts confirmed a critical role for adducin in locomotion.
Interpretation: Although likely a rare cause of cerebral palsy, our findings indicate a critical role for adducins in regu-
lating the activity of the actin cytoskeleton, suggesting that impaired adducin function may lead to neuromotor
impairment and further implicating abnormalities of the dynamic cytoskeleton as a pathogenic mechanism contribut-
ing to cerebral palsy.
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Cerebral palsy (CP) is a relatively common cause ofneuromotor disability, estimated to affect approxi-
mately 1 in 500 live births.1 Many cases of CP are
thought to result from prenatal or perinatal insults, identi-
fiable on magnetic resonance imaging (MRI) scans by
periventricular leukomalacia, diffuse white matter injury,
or encephalomalacia. However, approximately 20% of
children with CP have no identifiable etiology for their
symptoms, with normal or nonspecific findings on neuroi-
maging, suggesting that a significant number of cases may
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be heritable in nature.2 Thus far, several genes responsible
for inherited forms of spastic quadriplegic CP have been
identified, including the actin-capping protein KANK1
(Mendelian Inheritance in Man [MIM] # 612900)3 and
the adaptor protein complex-4 subunits AP4E1, AP4M1,
AP4B1, and AP4S1 (MIM # 612936, 613744, 614066,
614067),4–6 responsible for both endocytic and secretory
sorting of integral membrane proteins.
In mammalian systems, adducin proteins form com-
plexes with actin-spectrin, linking membranes to the
dynamic cytoskeleton. Adducins have a physiologic actin-
capping function, modulating the fast-growing end of actin
filaments and controlling actin molecule length. Prior stud-
ies have shown adducins to have effects on plasma mem-
brane stability,7 cell motility,8 synaptic vesicle=endosomal
recycling,9 cell–cell adhesion,10 cell proliferation,11 and
dendritic spine formation and retraction.12 An a adducin
polymorphism (rs4961) has been linked to CP in prior
association studies,13 and adducin hyperphosphorylation
has been identified in both human patients and mouse
models of amyotrophic lateral sclerosis.14 Here, we describe
the characterization of a defect in the adducin subunit
gene ADD3 in a consanguineous family with spastic diple-
gic or quadriplegic CP.
Patients and Methods
Ethics Statement
Written informed consent was provided for all participants
using an institutional review board–approved protocol.
Index Family
The index family was a consanguineous (second-cousin mar-
riage) Jordanian family with 4 affected individuals (Fig 1A).
Parents were examined and were unaffected. All children were
born at term after unremarkable pregnancies.
Patient Phenotype
No facial dysmorphism was evident. Spasticity was noted in
Patient II-1 at 3 months of age. Borderline microcephaly was
present (occipitofrontal circumference < 3%). Communicative
intent was limited to nodding yes=no and occasional vocaliza-
tion. Intermittent icterus developed during intercurrent illness
associated with mild conjugated hyperbilirubinemia. Nerve con-
duction study and electromyogram were normal. At age 16
years, she was nonambulatory, with severe spastic quadriplegia
and pyramidal tract signs without dystonia. She was gastros-
tomy tube-fed and dependent for all activities of daily living.
The second sibling (II-2) also exhibited spastic quadripare-
sis and cognitive impairment within the first year. He developed
epilepsy by age 2 years, which responded to anticonvulsant medi-
cations. Electroencephalogram demonstrated bifrontal spike–slow
wave discharges. Supranuclear gaze palsy was noted during the
preschool years but improved with time. Intermittent conjugated
hyperbilirubinemia developed during illness. Examination at age
13 years showed borderline microcephaly, dysarthria, dysphagia,
and exotropia. Electron microscopic analysis of a skin biopsy
showed normal morphology without inclusions. Bone marrow
biopsy performed at age 8 years showed sideroblastic anemia,
although peripheral smear with electron microscopy at age 14
years found no anemia or ringed sideroblasts.
The third child (II-3) was more mildly affected, with spas-
tic diplegia (Supplementary Video). Neuropsychological evalua-
tion disclosed borderline intellectual functioning, inattention, and
impulsivity. At age 7 years, examination found borderline micro-
cephaly, strabismus, and spastic diplegia. A single episode of con-
jugated hyperbilirubinemia occurred after orthopedic surgery.
The fourth child (II-4) was phenotypically normal at age
5 years.
The fifth child (II-5) showed early cognitive and neuro-
motor impairment. His examination at age 22 months demon-
strated convergence retraction nystagmus and strabismus. He
had borderline microcephaly, dysphagia, and spastic quadripare-
sis with pyramidal tract signs. Receptive understanding was
severely limited, and expressive speech was absent.
Diagnostic Workup
Diagnostic testing included normal karyotype and array com-
parative genomic hybridization. Complete blood count showed
intermittent macrocytic, normochromic anemia in several
affected children. Metabolic screening was unremarkable.
Muscle biopsy performed in II-1 and II-2 demonstrated
mild type 2 fiber atrophy with unremarkable histologic and elec-
tron microscopic appearance. Respiratory chain enzymology in
frozen muscle demonstrated a mild decrease in complex I activity
(mU=U citrate synthase (CS)). Analysis for mtDNA deletions,
duplications, and depletion and screens for MELAS (mitochon-
drial encephalomyopathy, lactic acidosis, and strokelike episodes),
MERRF (myoclonic epilepsy with ragged red fibers), and NARP
(neuropathy, ataxia, and retinitis pigmentosa) were negative.
Phenotypic features and workup are summarized in
Table 1. MRI features are depicted in Figure 1B–H and Table 2.
Spinal cord imaging was unremarkable.
Cell Culture
Fibroblast cell lines were established from patient skin biopsies.
Low-passage, age-matched cells were used for all experiments.
Neuroimaging
MRI images were obtained using a 3T Philips (Best, the Neth-
erlands) Achieva Scanner, with diffusion tensor imaging post-
processing via the Fibertrack Package (Philips).
Genotyping
Genotyping was performed using HumanCytoSNP-12 Bead-
Chips (Illumina, San Diego, CA), and homozygous regions
were annotated as previously described.15
Exome Sequencing
Coding sequence was captured using the SureSelect exome cap-
ture kit (Agilent, Santa Clara, CA). Adapter sequences were
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ligated, and enriched DNA samples were analyzed on the GAIIx
(Illumina). Paired-end reads of 42bp lengths were produced.
Sequence alignment; building, indexing, and sorting SAM
(Sequence Alignment=Map) files; and calling raw variants and
indels were performed using Burrows–Wheeler Aligner (http:==
io-bwa.sourceforge.net=), SAMTools (http:==samtools. sourceforge.
net=), and the Genomic Analysis Toolkit (https:==www.broadinstitute.
org=gsa=wiki=index.php=TheGenomeAnalysis Toolkit) and Pic-
ard (http:==picard.sourceforge.net=), respectively. Approximately
73.5 million sequence reads were produced per sample, with on-
target coverage of 98.75% of reads mapped to hg18. Average
read-depth was 356; in the chromosome 10 region of shared
homozygosity identified by single nucleotide polymorphism
(SNP) genotyping, average coverage depth was 380. A total of
14,427 nonunique, 12,627 unique, and 1,640 indel sequence
variants were detected. To assess variant functional impact, we
applied phastCons and PolyPhen-2.16,17
Sanger Sequencing
Genomic DNA was polymerase chain reaction–amplified
(sequences available upon request) and sequenced on an
ABI3730 sequencer (Life Technologies, Carlsbad, CA).
In Silico Analysis
Short linear protein-binding motifs (SLiMs) were predicted using
SLiMPred (http:==bioware.ucd.ie=compass=biowareweb=).18
FIGURE 1: Pedigree and neuroimaging findings of index family. (A) Family structure. (B) Frontotemporal predominant volume loss
was observed, with decreased white matter volume and mild ventriculomegaly in all family members. (C, D) Tiny periventricular T2
hyperintense foci were seen (arrows) in all family members. (E) Periventricular heterotopic gray matter was noted in patient II-2
(arrow). (F–H) Sagittal fractional anisotropy (FA) map generated from diffusion tensor imaging through the corpus callosum in con-
trol (above) and Patient II-2 (below). Color maps are based on major eigenvector orientation in each of the voxels: red 5 right (R)
to left (L), green 5 anterior (A) to posterior (P), blue 5 superior–inferior anatomical directions. When compared to an age-=sex-
matched control, substantial differences in the FA values of the body (0.413 6 0.194 [patient] vs. 0.799 6 0.087 [control]) of the
corpus callosum were evident. [Color figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
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Protein intrinsic disorder was predicted with IUPred
(http:==iupred.enzim.hu=).19 Three-class protein secondary
structure (helix, strand, and coil) was predicted by Distill
(http:==distill.ucd.ie=).20
Actin Capping
Actin-capping assays were performed using an Actin Polymer-
ization Biochem Kit (Cytoskeleton, Denver, CO).21 Pyrene-
labeled G-actin was incubated with cell lysates after 1lg=ml
lysophosphatidic acid stimulation for 2 hours.22
Colocalization
Fibroblasts were grown to near confluence, and cells were fixed
in 4% paraformaldehyde, treated with mouse anti-ADD1
(1:500; Abcam, Boston, MA) and rabbit anti-ADD3 (Novus
Biologicals, Littleton, CO), and visualized using Alexa Fluor
fluorophores (Life Technologies, Carlsbad, CA). Slides were
mounted using Vectashield H-1200 with DAPI (Vector Labora-
tories, Burlingame, CA), and z-stack images were taken using
an A1 TIRF confocal microscope (Nikon, Tokyo, Japan).
Colocalization was determined using the Nikon NIS Colocali-
zation module.
Proliferation and Migration
Cells were grown on poly-L-lysine coverslips (BD Biosciences,
Franklin Lake, NJ). A clear channel was mechanically intro-
duced, and the number of cells within the clearing was
counted.
Proliferation was estimated by the percentage of Ki-67–
positive cells, whereas migration was determined by subtract-
ing proliferating cells from total cell content within the region
of interest. For immunocytochemistry, cells were fixed and
stained as above, using anti-Ki-67 (1:300; Millipore, Billerica,
MA).
siRNA Knockdown
Control fibroblasts were treated with 75nM siRNA duplexes
targeted against human ADD3 (Origene, Rockville, MD) using
RNAiMAX (Invitrogen, Carlsbad, CA) for 48 hours. Transfec-
tion efficiency was determined using an fluorescein isothiocya-
nate–conjugated control (Life Technologies #2013) run in
parallel. Cell lysates were used for ADD3 immunoblot and
actin polymerization assay.
Endocytosis
Fibroblasts were transferred to ice-cold F12 with 50lg=ml
Alexa Fluor 488-transferrin. Cells were washed to remove excess
label, then incubated for 30 minutes at 37C to allow for trans-
ferrin uptake. Cells were fixed with 2% paraformaldehyde,
mounted with Prolong Gold Antifade and imaged using a 710
confocal microscope (Carl Zeiss, Oberkochen, Germany).
Image processing and evaluation were performed using Volocity
(Perkin Elmer, Waltham, MA).
TABLE 1. Clinical Features of Affected Family Members
Feature II-1 II-2 II-3 II-5
Sex F M F M
Age at last examination, yr 16 13 9 3
Neuromotor findings Spastic quadriplegia Spastic quadriplegia Spastic diplegia Spastic
quadriplegia
Intellectual disability Severe Severe Borderline Moderate
MRI Frontoparietal
volume loss; punctate
T2 hyperintensities
Periventricular T2
hyperintensities;
GM heterotopia
Normal Normal
EEG ND Bifrontal spike-wave ND ND
EMG/NCS Normal ND ND ND
Other findings Supranuclear gaze
palsy
ADHD Convergence-
retraction
nystagmus
ADHD 5 attention deficit–hyperactivity disorder; EEG 5 electroencephalogram; EMG 5 electromyogram; F 5 female; GM 5
gray matter; M 5 male; MRI 5 magnetic resonance imaging; NCS 5 nerve conduction study; ND 5 not done.
TABLE 2. Fractional Anisotropy Values of Major
White Matter Tracts
Control II-2
ALIC 0.506 6 0.142 0.515 6 0.176
BODY 0.582 6 0.112 0.413 6 0.194
EC 0.341 6 0.143 0.324 6 0.111
GENU 0.799 6 0.087 0.455 6 0.203
PLIC 0.619 6 0.166 0.679 6 0.163
ALIC 5 anterior limb of internal capsule; EC 5 external
capsule; PLIC 5 posterior limb of internal capsule.
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Drosophila Stocks
Strains were Cs (wild type), hts01103, Df(2R) BSC26 (Bloo-
mington Stock Center, Bloomington, IN), UAS-hts RNAi (line
103631; Vienna Drosophila RNAi Center, Vienna, Austria).
Applx-Gal4 was kindly provided by L. Torroya.
Western Blots
Immunoblotting used anti–adducin-related protein (1B1; 1:10)
and anti–beta-tubulin (E7; 1:50; Developmental Hybridoma
Bank, Iowa City, IA) and peroxidase-conjugated sheep anti-
mouse secondary antibody (1:10,000; Jackson laboratories, Bar
Harbor, ME).23 Fly head homogenates were prepared from 3-
to 6-day-old flies, and hts protein was detected using the ECL
system (GE Healthcare, Buckinghamshire, United Kingdom).
Paraffin Sections
Fly heads were fixed and embedded in paraffin. Seven-
micrometer sections were deparaffinized, mounted, and imaged
using a Zeiss Axioscope 2 microscope. Autofluorescence due to
endogenous eye pigmentation allowed visualization.24
Drosophila Behavioral Assay
The negative geotaxis assay was performed by transferring flies
to a graduated vial and tapping to the bottom of the vial.25
Percentages of flies climbing 8cm within 8 seconds post-tap
were recorded.
Results
Homozygosity Mapping
Given the inheritance pattern of the family, we performed
autozygosity mapping using llumina HumanCytoSNP-12
BeadChips in all family members. We identified 134 auto-
zygous segments that were 1Mb; however, only 2 auto-
zygous blocks on chromosome 10 were common to all
affected individuals and absent in unaffected family mem-
bers (physical position 99,527,480–103,563,212, and
105,450,391–114,830,484; hg18; Fig 2).
Exome Sequencing
Given the size of the autozygous region identified, we
applied a whole exome sequencing approach to identify
the causative variant in this family by sequencing individ-
ual II-2. We systematically filtered sequence variants by
focusing on homozygous variants within the linkage
region and filtering out known SNPs present in public
databases and in control exomes.26 Within the linked
regions of chromosome 10, on-target coverage was
99.24%. Using this approach, we identified homozygous
FIGURE 2: Homozygosity mapping, exome and Sanger sequencing, and filtering algorithm. Homozygous region on chromosome
10 shared by affected family members and filtering strategy applied to interrogate sequence variants (SVs) generated by exome
sequencing. A homozygous c.1100G>A mutation was found in all affected individuals, whereas unaffected individuals were het-
erozygous for this mutation. [Color figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
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variants in 5 genes (GBF1, ADD3, LDB3, BLNK,
and ABCC2) that fell within the chromosome 10
autozygous regions. Subsequent Sanger sequencing found
that homozygous mutations in only 2 of these genes,
ADD3 (c.1100G>A; ENST00000356080) and ABCC2
(c.4025C>A; ENST00000370449), segregated with dis-
ease status in the family (see Fig 2).
Mutations in ABCC2 (ENSG00000023839) cause
Dubin–Johnson syndrome (MIM # 237500), a well-
characterized autosomal recessive disorder that leads to
episodic jaundice and conjugated hyperbilirubinemia in
times of metabolic stress. As ABCC2 mutations have
never been associated with a neurological phenotype, we
propose that the novel homozygous mutation (p.S1342Y)
we identified in this gene cosegregates with the gene
responsible for the neurologic phenotype, residing within
the same haplotype block and accounting for the episodic
jaundice seen in affected family members.
Mutation Validation and In Silico Analysis
In contrast, the c.1100G>A (p.G367D) mutation identi-
fied in ADD3 (ENSG00000148700) represented a viable
candidate gene for the neurological phenotype in this fam-
ily, with both parents carrying heterozygous mutations.
Analysis of 208 ethnically matched Middle Eastern con-
trols and 450 mixed European controls revealed no var-
iants at this site. The ADD3 p.G367D mutation occurred
at a highly conserved residue that maps within the puta-
tive oligomerization domain27 of the adducin protein
(Supplementary Fig 1). In silico analysis using Distill
revealed that the p.G367D mutation was predicted to dis-
rupt the naturally occurring helix surrounding the muta-
tion site. This was associated with widespread disruption
of SLiMs as predicted by SLiMPred. This occurred both
at the mutation site (oligomerization domain) and
throughout the disordered region of the tail and
MARCKS domains (actin-binding domain).
Actin-Capping Studies
Immunoblot analysis of fibroblast lysates from Patients
II-1, II-2, and II-3 showed no difference in protein abun-
dance between wild-type and affected individuals (data not
shown). Similarly, no significant differences were detected
in levels of phosphorylated adducin (data not shown).
Immunohistochemistry of affected muscle biopsy samples
(II-1 and II-2) as well as confocal microscopic analysis of
affected cultured fibroblasts showed no consistent differ-
ence in either the expression or distribution of gamma
adducin (data not shown). However, fibroblast lysates
demonstrated a significant increase in lysophosphatidic
acid–stimulated actin polymerization in patient fibroblasts
when compared to wild type (Fig 3), consistent with
impaired actin capping activity in the mutant. siRNA
knockdown of the ADD3 transcript led to a similar
impairment of actin capping (Supplementary Fig 2), sug-
gesting that the p.G367D variant serves as a loss-of-
function mutation. Adducin normally functions as a heter-
odimer or heterotetramer comprised of a=b or a=c subu-
nits that serve to cap and bundle actin filaments, and
recruit spectrin.27 Both of these domains are predicted to
be disrupted by the p.G367D mutation (see Supplemen-
tary Fig 1C), although adducin monomers retain some
actin-capping activity within the neck–tail domain.28
Adducin Oligomerization
Recently, a adducin has been shown to traffic between the
nucleus and cytoplasm and to play a role in cell prolifera-
tion.11 Whereas the a and c subunits are ubiquitously
expressed, b subunit expression is limited to brain and
hematopoietic tissue. Adducin subunit composition seems
to finely regulate adducin activities, having effects on
long-term potentiation and motor function as well as the
phosphorylation status of individual subunits.29 For this
reason, we sought to characterize the effects of ADD3
p.G367D on the interaction of the a and c subunits.
The a adducin oligomerization domain was experi-
mentally determined to include residues 335–436
through studies of truncation mutants.27 Within this
domain, residues 360–386 are highly conserved between
species and adducin isoforms (see Supplementary Fig
1A); this critical region corresponds to residues 363–389
of c adducin. Furthermore, site-directed mutagenesis of
FIGURE 3: Mutation effects on actin-capping function. Lyso-
phosphatidic acid (LPA)-stimulated actin polymerization is
increased in mutant fibroblasts, consistent with impaired
adducin-mediated actin capping. Shown are mean values for
fibroblast lysates from 3 patients versus 3 age-matched con-
trols run in duplicate, representing results from 2 independ-
ent experiments, with mean 6 standard deviation depicted; p
< 0.0001 by Student t test. RFU 5 relative fluorescence units.
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residue 369 was shown to interfere with normal hetero-
mer formation.27 Given the potential for the ADD3
pG367D aspartic acid substitution within the oligomeri-
zation domain to influence c adducin interactions with
the a subunit, double-labeling experiments were per-
formed. These demonstrated a paucity of colocalization
in affected fibroblasts compared to controls (Fig 4A),
indicating an impairment of heteromer formation despite
adequate protein levels of each isoform. b Adducin
expression was not detected in either control or patient
fibroblasts, consistent with prior findings (data not
shown). Morphologically, mutant fibroblasts demon-
strated a lack of neuritelike processes as compared to
wild-type fibroblasts (see Fig 4A), consistent with the
role of c adducin in controlling process outgrowth.30
Adducin Function
a Adducin has been shown to influence rates of endocy-
tosis,31 cellular migration and proliferation through inter-
actions with protein kinase Cd,32 and mitotic spindles
and centrosomes,11 respectively, with implications for
functional neuronal connectivity. We thus evaluated
endocytosis as well as the migrational and proliferative
capacity of mutant fibroblasts. Although we found no
FIGURE 4: In vitro effects of ADD3 p.G367D. Colocalization of a and c adducin in wild-type versus ADD3 p.G367D cells. (A)
Adducin (a [green] and c [red]) colocalization in wild-type versus mutant ADD3 fibroblasts. Impaired colocalization is seen in
merge as affected fibroblasts (right) show diminished yellow coloration (representative images). (B) Degree of colocalization by
Pearson correlation coefficient (mean 6 standard deviation [SD]; 3 fields selected at random from 2 independent cultures of each
patient or age-matched control; p < 0.01 by Student t test). Proliferative capacity in oligomerization-defective mutants. (C) Ki-67-
positive cells (red) are significantly more abundant in mutant cells (DAPI counterstain). (D) ADD3 p.G367D mutant fibroblasts
show increased proliferation by Ki-67 staining as compared to wild type (mean 6 SD; 2 coverslips were seeded per patient or
age-matched control, and 6 images were analyzed from each coverslip; experiments were performed at least twice; p < 0.01 by
t test). Migration in oligomerization-defective mutants. (E) Mutant cells show increased migration into cell-free region (5 fields
selected at random from 2 independent cultures of each patient or age-matched control; mean 6 SD, p < 0.05 by t test). [Color
figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
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differences in transferrin endocytosis (Supplementary Fig
3), we found that both proliferation (see Fig 4C, D) and
migration (see Fig 4E) were significantly increased in
patient cells compared to controls. This may be due to
aberrant actin-capping activity. Alternatively, impaired
adducin heteromer formation may lead to alterations in
nuclear interactions of monomeric adducin. Although
additional studies will be required to elucidate the precise
mechanisms involved, the gray matter heterotopia seen in
Patient II-2 may be related to abnormal migration from
the periventricular germinal zone. Furthermore, given the
importance of adducin in regulating dendritic spine for-
mation, retraction, and remodeling,12 adducin mutations
could lead to neuron-specific defects in these processes.
These alterations could ultimately lead to impaired func-
tional connectivity, as evidenced by our diffusion tensor
imaging findings (see Fig 1F–H), which indicate abnor-
mal fiber tract properties, likely related to disruptions in
axonal connectivity, density, or integrity.
Phenotypic Characterization of Adducin Loss of
Function in Drosophila
Studies in Drosophila have shown an increase in synaptic
retractions as well as overgrowth of glutamatergic type Ib bou-
tons with loss of presynaptic hu-li tai shao (hts), theDrosophila
adducin homolog.33We sought to corroborate and extend our
proof-of-pathogenesis studies of the p.G367D mutation by
evaluating the effects of in vivo loss of function of theDrosoph-
ila adducin homolog (hts1103=Df, an hts hypomorph). Mutant
flies had no detectable hts protein (Fig 5). Lesions of brain
lamina and medulla were observed in both hts1103 and hts
RNAi knockdown. Finally, hts1103 flies displayed impaired
locomotion, consistent with a significant role for adducin=hts
in normal neuromotor function.
FIGURE 5: Loss of function of hts leads to neuromotor impairment in Drosophila. (A) Western blot showing that flies carrying
hts1103 over a genomic deletion do not show detectable protein levels. (B) Schematic of a horizontal section of a fly head
showing the optic system. The retina (re) is shown in dark gray, whereas the 4 optic neuropils, the lamina (la), medulla (me),
lobula (lo), and lobula plate (lp), are shown in light gray. The neuropil consists of axons and dendrites, whereas the cortex
region (white) houses neuronal cell bodies. (C) Thirty-day-old wild-type flies have an intact optic system (scale bar 5 25lm). (D)
At 1 day after eclosing from the pupal case, hts1103=Df flies do not show any lesions. (E) After 14 days, hts1103=Df flies have
developed vacuoles in the lamina (arrows). (F) Vacuoles extend into the medulla in a 4-week-old fly. (G) Fourteen-day-old
hts1103=Df flies show severe deficits in climbing up a tube (8cm) within 8 seconds. (H) Knocking down hts in motor neurons
also results in locomotion deficits in the fast phototaxis assay. Standard error of the mean and number of flies tested are indi-
cated; ***p < 0.001, *p < 0.05.
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Discussion
Prior studies in knockout mice have demonstrated impair-
ment of locomotor function and learning in b adducin
knockout mice.29 These findings accompanied changes in
subunit composition and phosphorylation state, support-
ing a role for the fine regulation of adducin activity in
normal learning and motor function. Additionally, loss of
a adducin has been shown to impair feedforward inhibi-
tion growth in the developing brain,34 with consequences
for learning and memory formation, again pointing to a
critical role for the adducins in the tightly regulated proc-
esses underlying functional central nervous system connec-
tivity. Although c adducin–null mice have been generated,
thus far, no significant red cell abnormalities have been
characterized,35 but to our knowledge, the brains of these
mice have not been studied in detail.
Given the interaction of adducin with spectrin, it is
intriguing that mutations in aII spectrin have previously
been identified as a cause of epilepsy, intellectual disability,
and spastic quadriparesis.36 Similar to adducin, KANK1
(also implicated in hereditary CP) plays an important role
in actin capping and controls cell migration, cell polarity,
and wound healing.37,38 CP-associated proteins adaptor
protein complex-4 (AP-4) and adducin each play an integral
role in the egress of vesicle cargoes from the trans-Golgi net-
work.39 AP-4 is also known to regulate the recycling of cell-
surface a-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid receptors,40 and adducin modulates cell surface expres-
sion of excitatory amino acid carrier 1,41 both key mecha-
nisms controlling glutamatergic neurotransmission in the
central nervous system. Taken together, these findings link
hereditary forms of CP and implicate abnormalities of com-
ponents of the dynamic cytoskeleton, process outgrowth,
and protein trafficking with neuromotor dysfunction.
In summary, we have identified a homozygous
p.G367D mutation in ADD3 in children with spastic
diplegic=quadriplegic CP and intellectual disability. Our in
vitro studies indicate that the gamma adducin p.G367D
mutant impairs heterodimer=heterotetramer formation,
disrupting the normally finely modulated regulation of cel-
lular actin polymer growth. The mutation leads to changes
in process extension, cell migration, and proliferation,
with implications for the pathogenesis of ADD3-associated
neuromotor impairment. Our in vitro findings are sub-
stantiated by our studies in Drosophila, which support a
critical role for adducin in normal neuromotor function.
Genetic forms of CP are likely to be individually rare,
as has been shown for intellectual disability.42 This can
present a challenge to ongoing efforts to identify relevant
disease genes, particularly given findings that suggest that
predicted loss of function sequence variants occur at greater
than expected frequency in most genomes.43 Such studies
underscore the importance of following up massively paral-
lel sequencing findings with mechanistic in vitro validation
of putative mutations. Evaluating larger cohorts of idio-
pathic CP patients will shed light on genetic contributions
to CP once enough patients are able to be enrolled.
Overall, the identification and characterization of causa-
tive genes may identify pathways that are important for nor-
mal neuromotor function and help identify new targets for
drug screens. Such studies may also shed light on essential
biological mechanisms that control neuron–neuron interac-
tions and regulate synaptic plasticity. Finally, increased recog-
nition of a genetic basis for many patients with CP may
have far-reaching implications for a condition long presumed
to be exclusively caused by prenatal or perinatal injury.
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